There’s An App For That

Digital therapeutics (DTx) offer promising solutions for consumers with behavioral health disorders. Our team has covered some of the initial real-world evaluations of DTx performance (see Digital Cognitive Behavioral Therapy More Effective Than Medication Therapy For Insomnia Treatment, People With Addiction Disorder Treated With Pear Therapeutics reSET Had Lower Six-Month Health Care Costs and Akili’s EndeavorRx Enhances Attentional Control In Children With ADHD).

But, a major barrier;to widespread adoption (and the financial success of the developers of DTx) has been the lack of clear reimbursement pathways—until now. As of January 1, 2025, the Centers . . .